At this time, there is no known cure for Persistent Hyperplastic Primary Vitreous (PHPV). However, there are medications that can be used to manage the symptoms associated with the condition. These medications include topical steroids, cycloplegic agents, and antiglaucoma medications. Additionally, surgery may be recommended to remove the abnormal tissue in the eye.

The risk factors for Persistent hyperplastic primary vitreous (PHPV) include:

1. Premature birth
2. Low birth weight
3. Family history of PHPV
4. Exposure to certain medications or toxins during pregnancy
5. Congenital heart defects
6. Genetic syndromes such as Stickler syndrome, Marfan syndrome, and Rubinstein-Taybi syndrome
7. Maternal diabetes
8. Maternal infection during pregnancy
9. Maternal smoking during pregnancy

1. Laser therapy: This is the most common treatment for persistent hyperplastic primary vitreous. It involves using a laser to destroy the abnormal tissue.

2. Vitrectomy: This is a surgical procedure in which the vitreous is removed from the eye. This can be done to remove the abnormal tissue and improve vision.

3. Intravitreal injections: This involves injecting medications directly into the vitreous to reduce inflammation and improve vision.

4. Photodynamic therapy: This involves using a light-activated drug to destroy the abnormal tissue.

5. Anti-inflammatory medications: These medications can be used to reduce inflammation and improve vision.

Persistent hyperplastic primary vitreous (PHPV) is a rare congenital eye disorder that is caused by the failure of the hyaloid artery to regress during fetal development. This results in the persistence of the primary vitreous, which is a jelly-like substance that normally disappears shortly after birth. The exact cause of PHPV is unknown, but it is believed to be due to genetic or environmental factors. Possible risk factors include maternal diabetes, maternal smoking, and maternal alcohol consumption.

The most common symptom of Persistent hyperplastic primary vitreous (PHPV) is a white or grayish-white mass in the center of the eye. Other symptoms may include decreased vision, strabismus (crossed eyes), and nystagmus (involuntary eye movements). In some cases, the mass may cause glauComa or cataracts.

Persistent hyperplastic primary vitreous (PHPV) is a rare congenital eye disorder that affects the development of the eye. It is characterized by the presence of a membrane in the vitreous cavity of the eye, which is filled with a jelly-like substance. This membrane can cause a variety of vision problems, including cataracts, glaucoma, and retinal detachment. Treatment for PHPV typically involves surgery to remove the membrane and restore normal vision.